MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome

被引：0

作者：

J C Hassel

A Sucker

L Edler

H Kurzen

I Moll

C Stresemann

K Spieth

C Mauch

K Rass

R Dummer

D Schadendorf

机构：

[1] Skin Cancer Unit,Department of Biostatistics

[2] German Cancer Research Center,Department of Epigenetics

[3] University Hospital Mannheim,Department of Dermatology

[4] German Cancer Research Center,Department of Dermatology

[5] German Cancer Research Center,Department of Dermatology

[6] Johann Wolfgang Goethe-University,Department of Dermatology

[7] University of Cologne,Department of Dermatology

[8] Saarland University Hospital,undefined

[9] University Hospital Zurich,undefined

[10] University Hospital Essen,undefined

[11] Hufelandstr. 55,undefined

[12] Bayer-Schering,undefined

[13] Müllerstr. 178,undefined

来源：

British Journal of Cancer | 2010年 / 103卷

关键词：

MGMT; gene methylation; melanoma; therapy toxicity; temozolomide;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：820 / 826

页数：6

共 50 条

[11] Successful treatment of metastatic alveolar rhabdomyosarcoma with MGMT gene promoter methylation by temozolomide-based combination chemotherapy
Kinoshita, Mariko
Yamada, Ai
Sawa, Daisuke
Kamimura, Sachiyo
Miyachi, Mitsuru
Moritake, Hiroshi
PEDIATRIC BLOOD & CANCER, 2018, 65 (01)
[12] MGMT promoter methylation in plasma of glioma patients receiving temozolomide
Fiano, Valentina
Trevisan, Morena
Trevisan, Elisa
Senetta, Rebecca
Castiglione, Anna
Sacerdote, Carlotta
Gillio-Tos, Anna
De Marco, Laura
Grasso, Chiara
Magistrello, Michela
Tondat, Fabrizio
Ruda, Roberta
Cassoni, Paola
Soffietti, Riccardo
Merletti, Franco
JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (02) : 347 - 357
[13] MGMT promoter methylation and temozolomide response in choroid plexus carcinoma
Kouichi Misaki
Mitsutoshi Nakada
Masanao Mohri
Yutaka Hayashi
Jun-ichiro Hamada
Brain Tumor Pathology, 2011, 28 : 259 - 263
[14] MGMT promoter methylation in plasma of glioma patients receiving temozolomide
Valentina Fiano
Morena Trevisan
Elisa Trevisan
Rebecca Senetta
Anna Castiglione
Carlotta Sacerdote
Anna Gillio-Tos
Laura De Marco
Chiara Grasso
Michela Magistrello
Fabrizio Tondat
Roberta Rudà
Paola Cassoni
Riccardo Soffietti
Franco Merletti
Journal of Neuro-Oncology, 2014, 117 : 347 - 357
[15] MGMT promoter methylation and temozolomide response in choroid plexus carcinoma
Misaki, Kouichi
Nakada, Mitsutoshi
Mohri, Masanao
Hayashi, Yutaka
Hamada, Jun-ichiro
BRAIN TUMOR PATHOLOGY, 2011, 28 (03) : 259 - 263
[16] Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma
Voelter, Verena
Diserens, Annie-Claire
Moulin, Alexandre
Nagel, Georg
Yan, Pu
Migliavacca, Eugenia
Rimoldi, Donata
Hamou, Marie-France
Kaina, Bernd
Leyvraz, Serge
Hegi, Monika E.
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1215 - 1218
[17] Correlation of Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas
J.L. Blanc
M. Wager
J. Guilhot
S. Kusy
B. Bataille
T. Chantereau
F. Lapierre
C.J. Larsen
L. Karayan-Tapon
Journal of Neuro-Oncology, 2004, 68 : 275 - 283
[18] Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas
Blanc, JL
Wager, M
Guilhot, J
Kusy, S
Bataille, B
Chantereau, T
Lapierre, F
Larsen, CJ
Karayan-Tapon, L
JOURNAL OF NEURO-ONCOLOGY, 2004, 68 (03) : 275 - 283
[19] Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status-Based Treatment Stratification
Medeiros, Bruno C.
Kohrt, Holbrook E.
Rajwanshi, Richa
Gotlib, Jason
Coutre, Steven
Liedtke, Michaela
Berube, Caroline
Zhang, Melody
Arber, Daniel A.
Zehnder, James L.
BLOOD, 2010, 116 (21) : 1357 - 1358
[20] Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients
Kavouridis, Vasileios K.
Ligon, Keith L.
Wen, Patrick Y.
Iorgulescu, J. Bryan
JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (01) : 111 - 116

← 1 2 3 4 5 →